Novel Therapies in Cancer: Trials and Tribulations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38975940.
- Also identified by DOI 10.1158/1078-0432.CCR-24-1127.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical trials are the backbone for advancing therapeutic options for patients diagnosed with cancer. Yet only 7.1% of patients with cancer participate in clinical trials in the United States. In this article, we review some of the reasons for poor accrual and discuss potential solutions. See related article by van Berge Henegouwen et al., p. 3937.
Medical subject headings
- Neoplasms
- Clinical Trials as Topic